Covington Venture Fund V-New Gen
Fund Price: $8.40 (as at May 17, 2013) 1-week chg: 0.37% YTD: -9.67%
Returns as at April 30, 2013
| Fund | Group Avg | Index* | |
|---|---|---|---|
| 1 Month | -2.56% | -0.71% | -4.81% |
| 3 Months | -7.56% | -2.63% | -6.51% |
| 6 Months | -15.33% | -8.75% | -4.44% |
| 1 Year | -26.99% | -13.63% | -5.19% |
| 2 Year Avg | 14.36% | -11.54% | -9.58% |
| 3 Year Avg | 11.63% | -8.69% | 1.69% |
| 4 Year Avg | 5.89% | -7.20% | 15.90% |
| 5 Year Avg | 0.96% | -8.33% | 2.66% |
| 10 Year Avg | -1.15% | -1.71% | 10.16% |
| 15 Year Avg | - | -1.04% | 6.34% |
| 20 Year Avg | - | -1.91% | 8.19% |
| Since Inception | -1.29% | - | - |
| 2012 | -6.97% | -10.29% | 2.46% |
| 2011 | 51.47% | -7.14% | -14.17% |
| 2010 | 0.97% | 2.86% | 38.53% |
| 3 year risk | 23.95 | 10.62 | 16.63 |
| 3 year beta | 0.04 | 0.06 | 1.00 |
*BMO Nesbitt Burns Cdn Small Cap Index
Growth of $10,000
Risk Measures as at April 30, 2013
Best/Worst 12 months (since inception)
| Best (ending Mar 12): | 79.82 | ||
| Worst (ending Apr 13): | -26.99 | ||
Volatility meter (Based on 3 year standard deviation from GlobeInvestor.com)
LowFund Objectives
The investment objective of the Fund is to achieve long-term capital appreciation by investing in securities of community small business investment fund corporations, which in turn will make eligible investments in start-up and early stage businesses whose focus is biotechnology and health care related. In addition, the investment objective of the fund is to return investors' capital by paying to them an amount equal to the subscription price paid for the Class A Shares on or about December 30, 2011.
Fund Facts
| Fund Sponsor: | Covington Group of Funds |
| Managed by: | Covington Group of Funds |
| Fund Type: | MF Corp |
| Inception Date: | December 2000 |
| Asset Class: | Retail Venture Capital |
| Quartile Rank: | 1 (3YR ending April 30, 2013) |
| Total Assets: | N/A |
| Mgmt Exp. Ratio (MER): | 7.36% |
| Management Fee: | 3.45% |
| Load Type: | Back End |
- Globe 5-Star Rating:
- RRSP Eligible:
- Canadian
- Min. Invest (initial):
- $500
- Subsequent:
- $50
- Min. Invest (initial RRSP):
- $500
- Subsequent RRSP:
- $50
- Closed:
- Yes
- Restricted:
- Yes
- Restriction:
- Not Available in BC,AL,SA,MA,PQ,NB,NS,NF,PEI,YK,NWT,NUV
Asset Allocation
Equity Sector Weightings
Fund Geography
Top Holdings
| Symbol | Company Name | Sector | Geographic Area | Asset Type | % of Total Assets | Performance as at May 17, 2013 1 Year Performance (%) | |||
|---|---|---|---|---|---|---|---|---|---|
| TILE-Q | Interface Inc. | - | United States | Stock | - | 46.02 | |||
| - | Zelos Therapeutics Inc. | - | United States | Stock | - | - | |||
| - | Insception Bioscience | - | United States | Stock | - | - | |||
| - | Stempath Inc. | - | United States | Stock | - | - | |||
Portfolio Manager(s)
Genesys Capital Partners - Mgmt Team
Genesys Capital Partners Inc.
Start Date: March, 2001
Fund Return: -1.30%
View fund manager performance report
Covington Mgmt-Mgmt Team
Covington Group of Funds
Start Date: March, 2001
Fund Return: -1.30%
Also manages:Covington Venture Fund VI-Ven Prtn, Covington Venture Fund VII-CapFirst
Mutual Fund data is provided by LIPPER, A THOMSON REUTERS COMPANY.
